To promote public awareness of head and neck cancer, board-certified oral and maxillofacial surgeons share facts and tips CHICAGO , April 11, 2024 /PRNewswire/ -- The Executive Board and Diplomates of the American Board of Oral and ...
AUSTIN, Texas , April 11, 2024 /PRNewswire/ -- Stamford Pharmaceuticals Inc, a clinical-stage biotechnology company developing science-driven immune therapies, today announced initiation of its locally advanced basal cell carcinoma ...
CLEVELAND , April 11, 2024 /PRNewswire/ -- More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat locally advanced metastatic p53 wild-type tumors has ...
MIAMI , April 11, 2024 /PRNewswire/ -- Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples. The results of the ...
SHANGHAI and SAN DIEGO , April 9, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today unveiled the latest research findings of GFH375, ...
NT-I7 maintains cancer-specific T-cell amplifying efficacy when combined with standard of care colorectal cancer therapy FOLFOX ® Study indicates interest for potential combination therapy with chemotherapeutic agents. ROCKVILLE, Md. ...
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma First development-stage asset to be added to the Essential Pharma portfolio and second product within ...
SAN DIEGO , April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX (capecitabine plus ...
– Consistent safety and efficacy profiles across adult and pediatric populations – – Majority of pediatric patients who achieved an overall response proceeded to transplant; patients receiving post-transplant revumenib maintenance ...
Trial has met primary endpoints of safety and immunogenicity and secondary endpoint for efficacy based on response rate Trial data published today in Nature Medicine Selected clinical trial data also presented at the 2024 AACR Annual ...
Researchers have led a new study that uncovers novel biomarkers in renal cell carcinomas. By conducting an integrative analysis of comprehensive proteogenomic datasets from both non-clear cell and clear cell renal carcinomas, the researchers have ...
In 2016, The Jackson Laboratory (JAX), a leading cancer research center, initiated the Maine Cancer Genomics Initiative (MCGI) to extend advanced cancer care to rural Maine patients. Through widespread access to genome tumor testing and targeted ...
Radiation therapy for prostate cancer often induces notable side effects among men, including fatigue , sleep disturbances, and feelings of anxiety and depression . However, incorporating mindfulness audio recordings into their treatment regimen has ...
A trial of the world's premier "personalized" mRNA vaccine targeting melanoma, the deadliest form of skin cancer , has commenced in the UK, marking a significant stride in oncological research and treatment ( ). Steve Young, a ...
Mice fed a vitamin D-rich diet displayed enhanced immune resistance against experimentally transplanted cancers and showed improved responses to immunotherapy . Similar outcomes were observed when a protein binding vitamin D in the blood, thus ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers